Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is more common in women, often appears as patchy hair loss, and is usually treated with steroid injections and minoxidil.

A new type of alopecia areata, called the "confetti variant," causes small bald spots that often heal on their own in a few months.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

Methotrexate can help some kids with severe hair loss regrow hair.

Alopecia areata and vitiligo can coexist, respond well to treatment, and may have a better prognosis together.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Alopecia areata in Romania has a high economic burden, with significant costs and unequal healthcare access.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Patients with anxiety or depression report more severe alopecia areata.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Dupilumab effectively treated severe alopecia areata in a child.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

New treatments for child hair loss due to immune issues are effective but not yet officially approved.

Early diagnosis and personalized treatment can lead to significant hair regrowth in children with alopecia areata.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

COVID-19 pandemic increased alopecia areata cases and hospitalizations.

Alopecia areata negatively affects self-esteem, relationships, and academics in young people.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

No link between scalp patterns and alopecia severity in children, but more severe cases often had nail abnormalities.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Adolescents with alopecia areata face more bullying and emotional challenges, needing support to improve their quality of life.

African American adults and non-White children experience more hair loss episodes than White patients with alopecia areata.

Alopecia areata incognito in children can be effectively treated with triamcinolone acetonide and supplements, leading to full hair regrowth.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.